Egros Fabrice

CIK 00015970851 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001597085

Recent Transactions

30 trades

Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-02-02+16,000→ 32,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-11-18$8.93/sh+14,000→ 30,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-11-18−14,000→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-11-18−30→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-11-18$18.03/sh−14,000→ 16,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-11-18$7.88/sh+30→ 16,030 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-11-18$18.03/sh−30→ 16,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-08-18−15,635→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-08-18$7.88/sh+15,635→ 31,635 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-08-18$15.75/sh−15,635→ 16,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-05-18$18.65/sh−1,683→ 16,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-05-18−1,683→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-05-18−11,926→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-05-18$7.88/sh+1,683→ 29,609 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-05-18$7.20/sh+11,926→ 27,926 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-05-18$18.65/sh−11,926→ 17,683 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-03-01$7.20/sh+74→ 26,241 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-03-01−74→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2021-03-01−10,167→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-03-01$6.35/sh+10,167→ 26,167 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-03-01$24.31/sh−10,167→ 16,074 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-03-01$24.31/sh−74→ 16,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-02-03+16,000→ 16,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2020-02-12+24,000→ 24,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2019-06-10+24,000→ 24,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2018-05-23+14,000→ 14,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2018-02-08+10,000→ 10,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2017-05-17+5,000→ 5,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2017-05-17+10,000→ 10,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2016-10-31+8,000→ 8,000 total

Companies

Syndax Pharmaceuticals Inc
Director
$SNDX

Recent Filings

Address

C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110

WALTHAM, MA, 02451

View on SEC.gov